Every earnings call for INSECTICID — management tone, guidance, KPIs and promise tracking, quarter by quarter.
INSECTICID · 6 transcripts · Chemicals · latest Q4 FY26Insecticides (India) Limited has 6 earnings calls on record here, a Chemicals company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
Revenue from Operations ₹2,140 cr (+7% YoY); EBITDA ₹227 cr (+3% YoY); EBITDA Margin 10.6%. FY26 Revenue from operations grew 7% to ₹2,140 crores.
Read full transcript & analysisRevenue ₹1,714 cr (+4% YoY); EBITDA ₹201 cr; PAT ₹128 cr. Q3 revenue growth of 8% despite challenging environment.
Read full transcript & analysisRevenue from Operations ₹638 cr (+2% YoY); EBITDA ₹89 cr (−1% YoY); PAT ₹59 cr (−3% YoY). Revenue grew 2% YoY to ₹638 crores despite challenging monsoon.
Read full transcript & analysisRevenue ₹691 cr (+5% YoY); EBITDA ₹85 cr (+18% YoY); PAT ₹58 cr (+18% YoY). Revenue of ₹691 crores, up 5.17% YoY.
Read full transcript & analysisEBITDA Margin (FY25) 11.1%; PAT (FY25) 7%; ROCE (FY25) 18%. Q4 FY25 revenue growth of ~32% YoY.
Read full transcript & analysisRevenue from Operations ₹358 cr (+18% YoY); EBITDA ₹61 cr (+154% YoY); EBITDA Margin 8.6%. 9M FY25 PAT of INR128 crores, highest in company history, with 36% YoY growth.
Read full transcript & analysis